News

Filter

1 to 9 of 46 results

Rapid expansion forecast for global Cushing’s syndrome drug market

Rapid expansion forecast for global Cushing’s syndrome drug market

29-01-2015

The global Cushing’s syndrome (CS) treatment market will expand rapidly in value from around $179 million…

CortendoEuropeHRA PharmaKetoconazoleMarkets & MarketingMetabolicsNormoCortNovartisPharmaceuticalRare diseasesSigniforUSA

Aegerion Pharma under SEC investigation

Aegerion Pharma under SEC investigation

14-01-2015

US biotech firm Aegerion Pharmaceuticals has revealed it is the subject of a US Securities and Exchange…

Aegerion PharmaceuticalsBiotechnologyBrazilCardio-vascularJuxtapidLegalMarkets & MarketingRare diseasesUSA

AOP Orphan brings Thromboreductin to Russian market

04-11-2014

Austria-based rare diseases specialist AOP Orphan is expanding its sales area for Thromboreductin (anagrelide)…

AnagrelideAOP OrphanMarkets & MarketingPharmaceuticalRare diseasesRussiaThromboreductin

Orphan drug market forecast to reach $176 billion by 2020

30-10-2014

In 2020, orphan drugs are expected to account for 19% of the total share of prescription drug sales excluding…

Markets & MarketingPharmaceuticalRare diseases

US and European orphan status for AbbVie’s glioblastoma candidate

US and European orphan status for AbbVie’s glioblastoma candidate

04-08-2014

Both the European Medicines Agency and the US Food and Drug Administration have granted orphan drug designation…

AbbVieABT-414Brain tumorEuropeGlioblastoma multiformeMarkets & MarketingOncologyPharmaceuticalRare diseasesRegulationUS Food and Drug AdministrationUSA

Ipsen takes step forward in the resupply of Increlex for the USA

Ipsen takes step forward in the resupply of Increlex for the USA

13-05-2014

Following previous availability problems, French drugmaker Ipsen said today that a supply of Increlex…

IncrelexIpsenMarkets & MarketingPharmaceuticalProductionRare diseasesUSA

Marken ready for orphan drug distribution

24-04-2014

USA-based Marken, a global clinical supply chain solutions provider, has released a new white paper which…

Markets & MarketingPharmaceuticalProductionRare diseases

SOBI assumes direct responsibility for rare disease drug Orfadin in the USA and Canada

SOBI assumes direct responsibility for rare disease drug Orfadin in the USA and Canada

01-04-2014

Biotech firm Swedish Orphan Biovitrum has assumed direct responsibility for the distribution of its proprietary…

BiotechnologyMarkets & MarketingNorthern EuropeOrfadinRare diseasesSobi

1 to 9 of 46 results

COMPANY SPOTLIGHT

Menarini

Back to top